Quick Answer
Adicet Bio, Inc. reported Research And Development Expense of $99.13 million for the year ending 2025.
- Adicet Bio, Inc. showed a decrease of -0.2% in Research And Development Expense from 2024 to 2025.
- This data is from Adicet Bio, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 9 years of available data (2017 to 2025), Adicet Bio, Inc.'s Research And Development Expense has grown by 488.7%.
- Historical annual values: Fiscal year 2025: $99.13 million | Fiscal year 2024: $99.32 million | Fiscal year 2023: $106.04 million | Fiscal year 2022: $71.25 million | Fiscal year 2021: $48.94 million | Fiscal year 2020: $34.33 million | Fiscal year 2019: $23.69 million | Fiscal year 2018: $14.72 million | Fiscal year 2017: $16.84 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: